Natural lipid-based nanoformulations for enhancing hepatoprotective activity: mechanisms, efficacy, and clinical translation

Lipid-based nanoformulations have emerged as a revolutionary approach to improve the delivery and effectiveness of hepatoprotective medicines sourced from natural products. This study offers a concentrated examination of sophisticated lipid-based carriers—namely liposomes, nanoemulsions, and solid lipid nanoparticles—and their function in enhancing bioavailability, liver targeting, and therapeutic index. Mechanistic insights are examined, highlighting how these systems regulate oxidative stress, inflammation, and mitochondrial dysfunction at the cellular level. The paper highlights the advantages of lipid-based encapsulation for natural chemicals such as curcumin, quercetin, and silymarin by synthesizing data from comparative studies, schematic drawings, and pharmacokinetic evaluations. Case studies and preclinical findings are rigorously analyzed to emphasize formulation-specific results, whilst clinical data offer a translational viewpoint. The paper examines technical advancements, such as CRISPR and AI, in enhancing nanoformulation design. Ultimately, regulatory, scalability, and safety challenges are assessed to inform future research and clinical implementation of lipid-based hepatoprotective treatments.